blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3294337

EP3294337 - TREATMENT OF DEBILITATING FATIGUE BY COMBINED USE OF 3(S)-3-[3-(METHYLSULFONYL)PHENYL]-1- PROPYLPIPERIDINE AND AN ANTI-DEPRESSIVE AGENT [Right-click to bookmark this link]
Former [2018/12]TREATMENT OF DEBILITATING FATIGUE
[2024/13]
StatusGrant of patent is intended
Status updated on  08.07.2024
Database last updated on 30.10.2024
FormerExamination is in progress
Status updated on  11.06.2024
FormerGrant of patent is intended
Status updated on  04.03.2024
FormerExamination is in progress
Status updated on  21.10.2019
FormerRequest for examination was made
Status updated on  16.02.2018
FormerThe international publication has been made
Status updated on  18.11.2016
Most recent event   Tooltip08.07.2024New entry: Communication of intention to grant a patent 
Applicant(s)For all designated states
Arvid Carlsson Research AB
c/o SEB Stiftelser
405 04 Göteborg / SE
[2022/18]
Former [2018/12]For all designated states
A.Carlsson Research AB
Thorild Wulffsgatan 50
413 19 Göteborg / SE
Inventor(s)01 / CARLSSON, Arvid
Thorild Wulffsgatan 50
413 19 Göteborg / SE
02 / GOTTFRIES, Carl-Gerhard
Svalebogatan 22
414 75 Göteborg / SE
 [2018/12]
Representative(s)AWA Sweden AB
Box 45086
104 30 Stockholm / SE
[N/P]
Former [2018/12]Awapatent AB
P.O. Box 45086
104 30 Stockholm / SE
Application number, filing date16723330.311.05.2016
[2018/12]
WO2016EP60562
Priority number, dateSE2015005061813.05.2015         Original published format: SE 1550618
[2018/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016180879
Date:17.11.2016
Language:EN
[2016/46]
Type: A1 Application with search report 
No.:EP3294337
Date:21.03.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 17.11.2016 takes the place of the publication of the European patent application.
[2018/12]
Search report(s)International search report - published on:EP17.11.2016
ClassificationIPC:A61K31/445, A61P25/00, A61K45/06, A61K31/137
[2024/13]
CPC:
A61K31/445 (EP,US); A61K45/06 (EP,US); A61P25/00 (EP);
A61K2300/00 (US); A61K31/137 (EP,US)
C-Set:
A61K31/445, A61K2300/00 (EP,US)
Former IPC [2018/12]A61K45/06, A61K31/445, A61P25/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/12]
TitleGerman:BEHANDLUNG VON LÄHMENDER ERMÜDUNG DURCH KOMBINIERTER VERWENDUNG VON 3(S)-3-[3-(METHYLSULFONYL)PHENYL]-1- PROPYLPIPERIDIN UND EINES ANTIDEPRESSIVUMS[2024/13]
English:TREATMENT OF DEBILITATING FATIGUE BY COMBINED USE OF 3(S)-3-[3-(METHYLSULFONYL)PHENYL]-1- PROPYLPIPERIDINE AND AN ANTI-DEPRESSIVE AGENT[2024/13]
French:TRAITEMENT DE LA FATIGUE DÉBILITANTE PAR L'UTILISATION COMBINÉE DE LA 3(S)-3-[3-(METHYLSULFONYL)PHENYL]-1- PROPYLPIPÉRIDINE ET D'UN ANTIDÉPRESSEUR[2024/13]
Former [2018/12]BEHANDLUNG VON LÄHMENDER ERMÜDUNG
Former [2018/12]TREATMENT OF DEBILITATING FATIGUE
Former [2018/12]TRAITEMENT DE LA FATIGUE DÉBILITANTE
Entry into regional phase11.12.2017National basic fee paid 
11.12.2017Designation fee(s) paid 
11.12.2017Examination fee paid 
Examination procedure11.12.2017Examination requested  [2018/12]
11.12.2017Date on which the examining division has become responsible
22.08.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
19.10.2018Amendment by applicant (claims and/or description)
24.10.2019Despatch of a communication from the examining division (Time limit: M06)
24.04.2020Reply to a communication from the examining division
27.11.2020Despatch of a communication from the examining division (Time limit: M06)
04.06.2021Reply to a communication from the examining division
30.03.2023Despatch of a communication from the examining division (Time limit: M06)
25.09.2023Reply to a communication from the examining division
02.10.2023Despatch of a communication from the examining division (Time limit: M02)
01.12.2023Reply to a communication from the examining division
05.03.2024Communication of intention to grant the patent
11.06.2024Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
09.07.2024Communication of intention to grant the patent
Request for further processing for:19.10.2018Request for further processing filed
19.10.2018Full payment received (date of receipt of payment)
Request granted
29.10.2018Decision despatched
Fees paidRenewal fee
31.05.2018Renewal fee patent year 03
28.05.2019Renewal fee patent year 04
30.04.2020Renewal fee patent year 05
19.05.2021Renewal fee patent year 06
31.05.2022Renewal fee patent year 07
15.05.2023Renewal fee patent year 08
28.03.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO0181343  (UPJOHN CO [US], et al);
 [A]WO2004010932  (MIGALY PETER [US]);
 [A]US2006154938  (KIKUCHI TETSURO [JP], et al);
 [Y]WO2008155357  (CARLSSON A RESEARCH AB [SE], et al);
by applicantUS5462947
 WO0146145
 US6903120
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.